MedTrace Logo

The Effects of a Novel Mitochondrial Substrate Supplement on Exercise Performance and Cognitive Function

NCT06374641 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-05-12

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the effects of taking a new supplement for 16 days on cognitive function and exercise performance, compared to a placebo (a supplement that looks and tastes the same, but doesn't have the same ingredients) in 40 healthy individuals - 20 young individuals (aged 18-30) and 20 older individuals (aged 50-65).

The main questions it aims to answer are:

* If taking the supplement for 16 days improves exercise performance, or the speed with which the body responds to the commencement of exercise.
* If taking the supplement improves cognitive function.

Participants will visit the lab on 5 separate occasions to:

* complete some cognitive tests
* complete exercise performance tests
* provide blood samples

All exercise tests will be on an exercise bike.

After 28 (or 46 for pre-menopausal females) days to make sure the supplement has left the body fully, participants will consume the opposite supplement and repeat the tests.

Conditions

  • Exercise Performance
  • Cognitive Function

Interventions

DIETARY_SUPPLEMENT

Mitochondrial Substrate Supplement

Mitochondrial Substrate supplement, 2xdaily 65 mL drink

DIETARY_SUPPLEMENT

Placebo Supplement

Placebo supplement, 2xdaily 65 mL drink

Sponsors & Collaborators

  • Mitocholine Ltd

    collaborator INDUSTRY

  • Innovate UK

    collaborator OTHER_GOV

  • University of Exeter

    lead OTHER

Principal Investigators

  • Andy M Jones, PhD, DSc · University of Exeter

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-26
Primary Completion
2025-06-06
Completion
2025-06-06

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06374641 on ClinicalTrials.gov